Applied DNA Sciences, Inc.
APDN
$4.83
$0.3156.98%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -17.82% | 47.17% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -17.82% | 47.17% | |||
| Cost of Revenue | 19.51% | -9.80% | |||
| Gross Profit | -45.80% | 179.34% | |||
| SG&A Expenses | 13.30% | -1.91% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 6.84% | 1.87% | |||
| Operating Income | -16.79% | 9.39% | |||
| Income Before Tax | -25.01% | 19.46% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -25.01% | 19.46% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 8.87% | 72.35% | |||
| Net Income | -25.19% | 19.94% | |||
| EBIT | -16.79% | 9.39% | |||
| EBITDA | -15.07% | 9.04% | |||
| EPS Basic | 44.84% | -73.96% | |||
| Normalized Basic EPS | 55.45% | 73.93% | |||
| EPS Diluted | 44.84% | -73.96% | |||
| Normalized Diluted EPS | 55.45% | 73.93% | |||
| Average Basic Shares Outstanding | 181.43% | 206.57% | |||
| Average Diluted Shares Outstanding | 181.43% | 206.57% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||